Created at	Source	Raw Value	Validated value
June 30, 2022, 4:30 p.m.	oms	• Patient diagnosed with SARS-CoV-2 infection at Screening by using the sponsor-supplied rapid SARS-CoV-2 diagnostic test or RT-PCR. • Oxygen saturation >94% on room air, and not requiring supplemental oxygen. • Patient whose onset of symptom is no more than 7 days prior to the study drug administration. • Patient had 1 or more of the SARS-CoV-2 infection-associated symptoms within but no more than 7 days prior to the study drug administration.	• Patient diagnosed with SARS-CoV-2 infection at Screening by using the sponsor-supplied rapid SARS-CoV-2 diagnostic test or RT-PCR. • Oxygen saturation >94% on room air, and not requiring supplemental oxygen. • Patient whose onset of symptom is no more than 7 days prior to the study drug administration. • Patient had 1 or more of the SARS-CoV-2 infection-associated symptoms within but no more than 7 days prior to the study drug administration.
Dec. 4, 2021, midnight	oms	• Patient diagnosed with SARS-CoV-2 infection at Screening by using the sponsor-supplied rapid SARS-CoV-2 diagnostic test or RT-PCR.. • Oxygen saturation >94% on room air / Not requiring supplemental oxygen. • Patient whose onset of symptom is no more than 7 days prior to the study drug administration	• Patient diagnosed with SARS-CoV-2 infection at Screening by using the sponsor-supplied rapid SARS-CoV-2 diagnostic test or RT-PCR.. • Oxygen saturation >94% on room air / Not requiring supplemental oxygen. • Patient whose onset of symptom is no more than 7 days prior to the study drug administration
July 30, 2021, 1:30 p.m.	oms	• Patient diagnosed with SARS-CoV-2 infection at Screening by using the sponsor-supplied rapid SARS-CoV-2 diagnostic test or RT-PCR.. • Oxygen saturation &gt,94&#37, on room air / Not requiring supplemental oxygen. • Patient whose onset of symptom is no more than 7 days prior to the study drug administration	• Patient diagnosed with SARS-CoV-2 infection at Screening by using the sponsor-supplied rapid SARS-CoV-2 diagnostic test or RT-PCR.. • Oxygen saturation &gt,94&#37, on room air / Not requiring supplemental oxygen. • Patient whose onset of symptom is no more than 7 days prior to the study drug administration